Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: aminolevulinic acid hydrochlorideFind trials that include: Any drugs shown Results 1-7 of 7 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Imaging Procedure Using Aminolevulinic Acid Hydrochloride in Finding Residual Tumor in Patients with Grade IV Malignant Gliomas Who Are Undergoing Surgery Status: ActivePhase: Phase IIType: DiagnosticAge: 18 and overTrial IDs: CASE 1305, NCI-2010-01385, NCT00752323 2. Aminolevulinic Acid in Measuring Brain Tumors in Patients With High Grade Glioma Undergoing Surgery Status: ActivePhase: Phase IIType: Diagnostic, TreatmentAge: 18 to 72Trial IDs: 10101, NCI-2011-01264, NCT01116661 3. Aminolevulinic Acid Hydrochloride in Visualizing Tumors in Patients with Newly Diagnosed or Recurrent Malignant Gliomas Undergoing Surgery Status: ActivePhase: Phase IIType: Diagnostic, TreatmentAge: 18 and overTrial IDs: WCI1999-11, NCI-2011-03426, IRB00051663, NCT01445691 4. Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients with Basal Cell Nevus Syndrome Status: Not yet activePhase: Phase IIType: Biomarker/Laboratory analysis, TreatmentAge: Not specifiedTrial IDs: CASE 2614, NCI-2014-02037, NCT02258243 5. Aminolevulinic Acid Hydrochloride and Photodynamic Therapy in Preventing Actinic Keratosis and Non-melanoma Skin Cancer in Patients Who Have Undergone Solid Organ Transplant Status: Not yet activePhase: Phase IIType: PreventionAge: 18 and overTrial IDs: PHX-16-0142-80-15, NCI-2017-00679, DUSA, NCT03110159 6. Quantification of ALA-induced PpIX Fluorescence in Patients with Newly Diagnosed or Recurrent Brain Tumors Undergoing Surgery Status: ActivePhase: Phase IType: DiagnosticAge: 21 and overTrial IDs: D13066, NCI-2015-01591, STUDY00028077, NCT02191488 7. Photodynamic Therapy and Vismodegib in Treating Patients with Multiple Basal Cell Cancers Status: ActivePhase: Phase IType: TreatmentAge: 18 and overTrial IDs: 1511201549, NCI-2016-00096, ML28849, NCT02639117 Select All on Page Start Over